Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-03-04, Stock:PFE, The news for the past five days is as follows:
2019-02-25: NEWS1: Technician says it's time to fade the biotech rally.NEWS2: Pharma CEOs to face tough questions about skyrocketing drug prices.NEWS3: Factbox: Pharma company executives to testify at U.S. Senate drug price hearing.NEWS4: There will be continued interest in gene therapy, says biotech analyst.NEWS5: Drug pricing showdown: Pharma CEOs set to testify before Congress on Capitol Hill Tuesday.NEWS6: Big Pharma to testify in Senate drug pricing hearing.NEWS7: The Zacks Analyst Blog Highlights: Walmart, Pfizer, Eli Lilly, Merck and Microsoft.NEWS8: The Zacks Analyst Blog Highlights: Walmart, Pfizer, Eli Lilly, Merck and Microsoft.NEWS9: Dow’s Best-Performing Stock in 2018 Gets Vote of Confidence.NEWS10: Healthcare Stocks Leading the Sector.NEWS11: What's in the Cards for Nektar (NKTR) This Earnings Season?.NEWS12: What's in the Cards for Nektar (NKTR) This Earnings Season?.NEWS13: The Zacks Analyst Blog Highlights: Walmart, Pfizer, Eli Lilly, Merck and Microsoft.NEWS14: What's in the Cards for Nektar (NKTR) This Earnings Season?.
2019-02-26: NEWS1: Lawmakers grill top pharma execs over high drug costs.NEWS2: Congress Grills Drugmakers: 5 Key Takeaways.NEWS3: Congress Grills Drugmakers: 5 Key Takeaways.NEWS4: Senators grill pharmaceutical executives over rising drug prices.NEWS5: Corcept (CORT) Q4 Earnings Beat Estimates, Revenues In Line.NEWS6: Corcept (CORT) Q4 Earnings Beat Estimates, Revenues In Line.NEWS7: Fed Chair Jerome Powell slams ballooning healthcare spending.NEWS8: Congress Grills Drugmakers: 5 Key Takeaways.NEWS9: Corcept (CORT) Q4 Earnings Beat Estimates, Revenues In Line.NEWS10: The Latest: Senators urge pharma CEOs to rein in lobbyists.NEWS11: The Latest: Pharma CEOs deny tactics to block competition.NEWS12: The Latest: Pharma CEOs push back on quick fixes for prices.NEWS13: Aerie (AERI) Q4 Earnings Miss, Rhopressa Gains Traction.NEWS14: Aerie (AERI) Q4 Earnings Miss, Rhopressa Gains Traction.NEWS15: Senators say will support Judiciary panel if it looks into drug patents.NEWS16: Senators grill pharma execs over prescription drug prices.NEWS17: Aerie (AERI) Q4 Earnings Miss, Rhopressa Gains Traction.NEWS18: Health Care Sector Update for 02/26/2019: NVCN, THC, MNK, JNJ, PFE, ABT, MRK, AMGN.NEWS19: Health Care Sector Update for 02/26/2019: NVCN, THC, MNK, JNJ, PFE, ABT, MRK, AMGN.NEWS20: Better Buy: GlaxoSmithKline vs. Eli Lilly.NEWS21: Better Buy: GlaxoSmithKline vs. Eli Lilly.NEWS22: [$$] Pharmaceutical Industry CEOs Face Senate Hearing on Drug Prices.
2019-02-27: NEWS1: Big Pharma's Showdown With Congress Over Drug Pricing: What It Really Means for You.NEWS2: Big Pharma's Showdown With Congress Over Drug Pricing: What It Really Means for You.NEWS3: Big Pharma&apos;s Showdown With Congress Over Drug Pricing: What It Really Means for You.NEWS4: IUSG, PFE, USB, ISRG: ETF Inflow Alert.NEWS5: IUSG, PFE, USB, ISRG: ETF Inflow Alert.NEWS6: The patent system ‘keeps American drug prices so high’.NEWS7: Astrazeneca PLC (AZN) Ex-Dividend Date Scheduled for February 28, 2019.NEWS8: Astrazeneca PLC (AZN) Ex-Dividend Date Scheduled for February 28, 2019.NEWS9: Perrigo Company (PRGO) Ex-Dividend Date Scheduled for February 28, 2019.NEWS10: Perrigo Company (PRGO) Ex-Dividend Date Scheduled for February 28, 2019.
2019-02-28: NEWS1: Top technician says charts point to healthy gains ahead for this stock.NEWS2: After Hours Most Active for Feb 28, 2019 :  CSCO, ZTO, ABEV, CMCSA, AAPL, MSFT, ATVI, BAC, VALE, KKR, SBUX, PFE.NEWS3: After Hours Most Active for Feb 28, 2019 :  CSCO, ZTO, ABEV, CMCSA, AAPL, MSFT, ATVI, BAC, VALE, KKR, SBUX, PFE.NEWS4: Antares Pharma Inc (ATRS) Q4 2018 Earnings Conference Call Transcript.NEWS5: Dow Movers: DWDP, PFE.NEWS6: Dow Movers: DWDP, PFE.NEWS7: Pfizer Announces Serotypes Included in 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older.
2019-03-01: NEWS1: 5 Pharmaceutical Stocks With Big Moats and Bridges.NEWS2: 5 Pharmaceutical Stocks With Big Moats and Bridges.NEWS3: After Hours Most Active for Mar 1, 2019 :  ABEV, GE, XOM, PFE, AR, TSM, SGMS, AAPL, SHY, MSFT, MCHI, INTC.NEWS4: After Hours Most Active for Mar 1, 2019 :  ABEV, GE, XOM, PFE, AR, TSM, SGMS, AAPL, SHY, MSFT, MCHI, INTC.NEWS5: Nektar (NKTR) Q4 Earnings Beat, NKTR-181 Review Extended.NEWS6: Nektar (NKTR) Q4 Earnings Beat, NKTR-181 Review Extended.NEWS7: Pharma Stock Roundup: Roche to Buy ONCE, Lawmakers Grill CEOs Over High Drug Prices.NEWS8: Pharma Stock Roundup: Roche to Buy ONCE, Lawmakers Grill CEOs Over High Drug Prices.NEWS9: Pharma Stock Roundup: Roche to Buy ONCE, Lawmakers Grill CEOs Over High Drug Prices.NEWS10: Nektar (NKTR) Q4 Earnings Beat, NKTR-181 Review Extended.NEWS11: Novartis AG (NVS) Ex-Dividend Date Scheduled for March 04, 2019.NEWS12: Novartis AG (NVS) Ex-Dividend Date Scheduled for March 04, 2019.NEWS13: Nektar Therapeutics (NKTR) Q4 2018 Earnings Conference Call Transcript.NEWS14: Pfizer Receives Positive CHMP Opinion for LORVIQUA® (lorlatinib) for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer.NEWS15: Pfizer unit Meridian under civil investigation by U.S. Attorney.NEWS16: ICU Medical Inc (ICUI) Q4 2018 Earnings Conference Call Transcript.

Answer: Decrease